Cargando...
Obinutuzumab for the treatment of patients with previously untreated chronic lymphocytic leukemia: overview and perspective
Chronic lymphocytic leukemia (CLL) is the most common lymphoproliferative disorder in the Western world and predominantly affects older people. Until recently, most studies in CLL focused on younger patients in whom intensive therapy with the addition of rituximab to fludarabine and cyclophosphamide...
Gardado en:
| Publicado en: | Ther Adv Hematol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
SAGE Publications
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4530370/ https://ncbi.nlm.nih.gov/pubmed/26288711 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620715586528 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|